Jeffrey A Bogosian Md is categorized under Orthopedic Doctors and Physicians in Los Angeles, CA and active since 1988.
Jeffrey A Bogosian Md was established in 1988, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Orthopedic Doctors and Physicians business, which does work in the B2C market, and is classified as a Orthopedic Doctors and Physicians, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Jeffery A Bogosian at the company’s single location by writing to 5230 Pcf Cncurse Drive 110, Los Angeles, California CA 90045 or by phoning (310) 643-0821. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Jeffrey A Bogosian Md |
Contact Person: | Jeffery A Bogosian |
Address: | 5230 Pcf Cncurse Drive 110, Los Angeles, California 90045 |
Phone Number: | (310) 643-0821 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 1988 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Orthopedic Doctors and Physicians |
SIC Code: | 8011 |
NAICS Code: | 621111 |
Share This Business: |
Jeffrey A Bogosian Md was started in 1988 to provide professional Orthopedic Doctors and Physicians under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Jeffery A Bogosian for inquiries that concern Jeffrey A Bogosian Md by calling the company number (310) 643-0821, as your correspondence is most welcome. Additionally, the physical location of the single location of Jeffrey A Bogosian Md can be found at the coordinates 33.927536,-118.372761 as well as the street address 5230 Pcf Cncurse Drive 110 in Los Angeles, California 90045.
For its online presence, you may visit Jeffrey A Bogosian Md’s website at and engage with its social media outlets through on Twitter and on Facebook.